Lyme arthritis in children: Is chronic arthritis a common complication?

Journal of Rheumatology

Volumn 27, Issue 8, 2000, Pages 1836-1838

  Sood, S K ^a   Ilowite, N T ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; LYME DISEASE VACCINE;

ADOLESCENT; ANTIBIOTIC THERAPY; BORRELIA BURGDORFERI; CHILD; CHRONIC ARTHRITIS; EDITORIAL; FEMALE; GERMANY; HUMAN; LYME DISEASE; MALE; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; TICK BITE;

ADOLESCENT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; CEFTRIAXONE; CHILD; CHILD, PRESCHOOL; DOXYCYCLINE; FEMALE; HUMANS; INFANT; LYME DISEASE; LYME DISEASE VACCINES; MALE;

EID: 0033847319     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (22)

1. Lyme arthritis: An epidemic of oligoarticular arthritis in children and adults in three Connecticut communities
2. Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group
3. Lyme arthritis in children and adolescents: Outcome 12 months after initiation of antibiotic therapy
4. Lyme arthritis in children: Clinical epidemiology and long-term outcomes
5. The long-term course of Lyme arthritis in children
6. Lyme disease
7. Lyme disease associated with fibromyalgia
8. Lyme arthritis as the incorrect diagnosis in pediatric and adolescent fibromyalgia
9. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi
10. Treatment of Lyme arthritis
11. Occurrence of severe destructive Lyme arthritis in hamsters vaccinated with outer surface protein A and challenged with Borrelia burgdorferi
12. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA
13. Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotype
14. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium
15. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group
16. Polyglot and polymorphism. An HLA update
17. Identification of LFA-1 as a candidate autoantigen in treatment- resistant Lyme arthritis
18. Multiple cross-reactive self-ligands for Borrelia burgdorferi-specific HLA-DR4-restricted T cells
19. The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis
20. Safety and immunogenicity of an outer surface protein A vaccine in subjects with previous Lyme disease
21. Evaluation of reactogenicity and immunogenicity of booster doses of LYMErix((TM)), recombinant L-OspA vaccine against Lyme disease
22. Recommendations for the use of Lyme disease vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP)